From: Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China
Radiographic and laboratory findings | Normal Range | Case 1 | Case 2 | Case 3 | Case 4 |
---|---|---|---|---|---|
After admission | |||||
White blood cell count, × 109/L | 3.5–9.5 | 4.21 | 10.91↑ | 4.86 | 5.46 |
Neutrophil count, × 109/L | 1.8–6.3 | 2.05 | 4.11 | 3.8 | 3.53 |
Lymphocyte count, × 109/L | 1.1–3.2 | 1.3 | 5.85 | 0.57↓ | 1.2 |
Hemoglobin, g/L | 130–175 | 101↓ | 118↓ | 133 | 152 |
Platelet count, ×109/L | 125–350 | 350 | 202 | 180 | 182 |
Procalcitonin, ng/mL | <  0.05 | <  0.05 | 0.1↑ | <  0.05 | 0.25 |
C-reactive protein, mg/L | 0–10 | NA | 36.2↑ | NA | NA |
Abnormalities on chest X-ray/CT | No | No (Fig. 1a) | Bilateral patchy shadowing (Fig. 1d) | No (Fig. 1f) | No (Fig. 1k) |
After fever onset | |||||
White blood cell count, ×109/L | 3.5–9.5 | 2.86↓ | 6.67 | 2.7↓ | 9.36 |
Neutrophil count, ×109/L | 1.8–6.3 | 1.79↓ | 3.55 | 1.21↓ | 8.73 |
Lymphocyte count, ×109/L | 1.1–3.2 | 0.4↓ | 2.4 | 0.88↓ | 0.28↓ |
Hemoglobin, g/L | 130–175 | 114↓ | 112↓ | 115↓ | 102↓ |
Platelet count, ×109/L | 125–350 | 156 | 177 | 280 | 50↓ |
Procalcitonin, ng/mL | <  0.05 | <  0.05 | 0.57↑ | <  0.05 | <  0.05 |
C-reactive protein, mg/L | 0–10 | 0.7 | 77.9↑ | 1.3 | 18.1↑ |
Influenza A or B virus detection | Negative | Negative | Negative | Negative | Influenza A virus (+) |
1–3-β-D polyglucosan (pg/ml) | (Neg.) < 60 (Pos.) > 110 | NA | < 10 | NA | 165.7↑ |
Abnormalities on chest X-ray/CT | No | Interstitial abnormalities (Fig. 1b) | Progress of bilateral lung diseases (Fig. 1e) | Local patchy shadowing (Fig. 1g) | Bilateral patchy shadowing (Fig. 1l) |
Lymphocyte subsets (count/μl) | |||||
CD3+T cells | 805–4459 | 435↓ | 297↓ | 865 | 335↓ |
CD3+CD4+T cells | 345–2350 | 290↓ | 115↓ | 482 | 148↓ |
CD3+CD8+T cells | 345–2350 | 142↓ | 184↓ | 341↓ | 185↓ |
B cells | 240–1317 | 12↓ | 4213↑ | 44↓ | 41↓ |
NK cells | 210–1514 | 59↓ | 132↓ | 154↓ | 43↓ |
Before discharge from hospital or dead | |||||
White blood cell count, ×109/L | 3.5–9.5 | 3.12↓ | 16.52↑ | 4.04 | 6.28 |
Neutrophil count, ×109/L | 1.8–6.3 | 2.18 | 7.37↑ | 2.22 | 5.34 |
Lymphocyte count, ×109/L | 1.1–3.2 | 0.41↓ | 7.94↑ | 1.07↓ | 0.55↓ |
Hemoglobin, g/L | 130–175 | 110.1↓ | 98.7↓ | 107.3↓ | 133.5 |
Platelet count, ×109/L | 125–350 | 156 | 44↓ | 151 | 92↓ |
Procalcitonin, ng/ml | <  0.05 | <  0.05 | 1.48↑ | <  0.05 | NA |
C-reactive protein, mg/L | 0–10 | 0.7 | 138.4↑ | NA | NA |
Detection of SARS-CoV-2 in throat swab samples | |||||
Dates of positive results | / | 26 January 30 January 3 February 8 February | 25 January 28 January 1 February 5 February | 23 January 30 January 3 February 9 February | 1 February 4 February 8 February 12 February |
Negativity time of SARS-CoV-2a | / | 13 February | / | 15 February | 10 March |